Plunkett Research Online: Abeona Therapeutics Inc

ABEONA THERAPEUTICS INC (ABEO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Abeona Therapeutics, Inc. is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Its mission is to provide advanced treatments for rare diseases and to find cures. Gene therapy is the use of DNA as a potential therapy to treat .....



Abeona Therapeutics Inc
Ticker: ABEO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 646-813-4712
Fax:
Address: 1330 Avenue of the Americas
33rd Floor
New York, NY 10019 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Development
Drug Delivery Systems
Polymer Technology
Oncology Products
ContactsDescription

Joao SiffertCEO/Director
Christine SilversteinCFO
See More
Abeona Therapeutics, Inc. is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Its mission is to provide advanced treatments for rare diseases and to find cures. Gene therapy is the use of DNA as a potential therapy to treat .....See More See More

Auditor: WHITLEY PENN LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Salt Diafiltration Process
EB-101
ABO-102
ABO-101
ABO-202
ABO-201
ABO-401
ABO-50X
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: